We then performed a correlation analysis between the signature genes expression and drug susceptibility, uncovering that the expression of genes CLEC14A and CYYR1 was significantly negatively correlated with sensitivity to all drugs (Fig 9B), suggesting their potential key roles in HCC progression and treatment response. Here, CLEC14A is linked to hepatocellular carcinoma.